<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-01-24" modified="2020-10-07" version="204">
<accession>Q9UNQ0</accession>
<accession>A0A1W3</accession>
<accession>A8K1T5</accession>
<accession>O95374</accession>
<accession>Q4W5I3</accession>
<accession>Q53ZQ1</accession>
<accession>Q569L4</accession>
<accession>Q5YLG4</accession>
<accession>Q86V64</accession>
<accession>Q8IX16</accession>
<accession>Q96LD6</accession>
<accession>Q96TA8</accession>
<accession>Q9BY73</accession>
<accession>Q9NUS0</accession>
<name>ABCG2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="48">Broad substrate specificity ATP-binding cassette transporter ABCG2</fullName>
<ecNumber evidence="10 41">7.6.2.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ATP-binding cassette sub-family G member 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Breast cancer resistance protein</fullName>
</alternativeName>
<alternativeName>
<fullName>CDw338</fullName>
</alternativeName>
<alternativeName>
<fullName>Mitoxantrone resistance-associated protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Placenta-specific ATP-binding cassette transporter</fullName>
</alternativeName>
<alternativeName>
<fullName>Urate exporter</fullName>
</alternativeName>
<cdAntigenName>CD338</cdAntigenName>
</protein>
<gene>
<name type="primary">ABCG2</name>
<name type="synonym">ABCP</name>
<name type="synonym">BCRP</name>
<name type="synonym">BCRP1</name>
<name type="synonym">MXR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Cancer Res." volume="58" first="5337" last="5339">
<title>A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.</title>
<authorList>
<person name="Allikmets R."/>
<person name="Schriml L.M."/>
<person name="Hutchinson A."/>
<person name="Romano-Spica V."/>
<person name="Dean M."/>
</authorList>
<dbReference type="PubMed" id="9850061"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS GLU-166 AND SER-208</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="15665" last="15670">
<title>A multidrug resistance transporter from human MCF-7 breast cancer cells.</title>
<authorList>
<person name="Doyle L.A."/>
<person name="Yang W."/>
<person name="Abruzzo L.V."/>
<person name="Krogmann T."/>
<person name="Gao Y."/>
<person name="Rishi A.K."/>
<person name="Ross D.D."/>
</authorList>
<dbReference type="PubMed" id="9861027"/>
<dbReference type="DOI" id="10.1073/pnas.95.26.15665"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="2569" last="2569">
<authorList>
<person name="Doyle L.A."/>
<person name="Yang W."/>
<person name="Abruzzo L.V."/>
<person name="Krogmann T."/>
<person name="Gao Y."/>
<person name="Rishi A.K."/>
<person name="Ross D.D."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:9861027</scope>
</reference>
<reference key="4">
<citation type="submission" date="2001-03" db="EMBL/GenBank/DDBJ databases">
<title>Breast cancer resistance protein constitutes a 140-kDa complex as a homodimer.</title>
<authorList>
<person name="Kage K."/>
<person name="Tsukahara S."/>
<person name="Sugiyama T."/>
<person name="Asada S."/>
<person name="Ishikawa E."/>
<person name="Tsuruo T."/>
<person name="Sugimoto Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="2827" last="2832">
<title>Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.</title>
<authorList>
<person name="Komatani H."/>
<person name="Kotani H."/>
<person name="Hara Y."/>
<person name="Nakagawa R."/>
<person name="Matsumoto M."/>
<person name="Arakawa H."/>
<person name="Nishimura S."/>
</authorList>
<dbReference type="PubMed" id="11306452"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Nat. Med." volume="7" first="1028" last="1034">
<title>The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.</title>
<authorList>
<person name="Zhou S."/>
<person name="Schuetz J.D."/>
<person name="Bunting K.D."/>
<person name="Colapietro A.M."/>
<person name="Sampath J."/>
<person name="Morris J.J."/>
<person name="Lagutina I."/>
<person name="Grosveld G.C."/>
<person name="Osawa M."/>
<person name="Nakauchi H."/>
<person name="Sorrentino B.P."/>
</authorList>
<dbReference type="PubMed" id="11533706"/>
<dbReference type="DOI" id="10.1038/nm0901-1028"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="FASEB J." volume="17" first="2085" last="2087">
<title>The expression and functional characterization of ABCG2 in brain endothelial cells and vessels.</title>
<authorList>
<person name="Zhang W."/>
<person name="Mojsilovic-Petrovic J."/>
<person name="Andrade M.F."/>
<person name="Zhang H."/>
<person name="Ball M."/>
<person name="Stanimirovic D.B."/>
</authorList>
<dbReference type="PubMed" id="12958161"/>
<dbReference type="DOI" id="10.1096/fj.02-1131fje"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS GLU-166 AND SER-208</scope>
<source>
<tissue>Brain endothelium</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2001-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Yoshikawa M."/>
<person name="Yabuuchi H."/>
<person name="Ikegami Y."/>
<person name="Ishikawa T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LYS-141</scope>
</reference>
<reference key="9">
<citation type="submission" date="2003-06" db="EMBL/GenBank/DDBJ databases">
<title>Cell line K562 resistant to Hoechst 33342.</title>
<authorList>
<person name="Sudarikov A."/>
<person name="Makarik T."/>
<person name="Andreeff M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT PRO-316</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Hippocampus</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2006-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS MET-12; LYS-141; HIS-296 AND THR-528</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT LYS-141</scope>
<source>
<tissue>Pancreas</tissue>
<tissue>PNS</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="8" last="13">
<title>Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.</title>
<authorList>
<person name="Miyake K."/>
<person name="Mickley L."/>
<person name="Litman T."/>
<person name="Zhan Z."/>
<person name="Robey R.W."/>
<person name="Cristensen B."/>
<person name="Brangi M."/>
<person name="Greenberger L."/>
<person name="Dean M."/>
<person name="Fojo T."/>
<person name="Bates S.E."/>
</authorList>
<dbReference type="PubMed" id="9892175"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 294-655 (ISOFORM 1)</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Mol. Cancer Ther." volume="1" first="417" last="425">
<title>Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.</title>
<authorList>
<person name="Allen J.D."/>
<person name="van Loevezijn A."/>
<person name="Lakhai J.M."/>
<person name="van der Valk M."/>
<person name="van Tellingen O."/>
<person name="Reid G."/>
<person name="Schellens J.H."/>
<person name="Koomen G.J."/>
<person name="Schinkel A.H."/>
</authorList>
<dbReference type="PubMed" id="12477054"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="22644" last="22649">
<title>ABCG2 transports sulfated conjugates of steroids and xenobiotics.</title>
<authorList>
<person name="Suzuki M."/>
<person name="Suzuki H."/>
<person name="Sugimoto Y."/>
<person name="Sugiyama Y."/>
</authorList>
<dbReference type="PubMed" id="12682043"/>
<dbReference type="DOI" id="10.1074/jbc.m212399200"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="19781" last="19789">
<title>Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2.</title>
<authorList>
<person name="Xu J."/>
<person name="Liu Y."/>
<person name="Yang Y."/>
<person name="Bates S."/>
<person name="Zhang J.T."/>
</authorList>
<dbReference type="PubMed" id="15001581"/>
<dbReference type="DOI" id="10.1074/jbc.m310785200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="5420" last="5429">
<title>N-linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.</title>
<authorList>
<person name="Diop N.K."/>
<person name="Hrycyna C.A."/>
</authorList>
<dbReference type="PubMed" id="15807535"/>
<dbReference type="DOI" id="10.1021/bi0479858"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION AT ASN-596</scope>
<scope>LACK OF GLYCOSYLATION AT ASN-418 AND ASN-557</scope>
<scope>MUTAGENESIS OF ASN-418; ASN-557 AND ASN-596</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Biochim. Biophys. Acta" volume="1668" first="53" last="63">
<title>Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.</title>
<authorList>
<person name="Oezvegy-Laczka C."/>
<person name="Koebloes G."/>
<person name="Sarkadi B."/>
<person name="Varadi A."/>
</authorList>
<dbReference type="PubMed" id="15670731"/>
<dbReference type="DOI" id="10.1016/j.bbamem.2004.11.005"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ARG-482</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="J. Cell Sci." volume="118" first="1417" last="1426">
<title>Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.</title>
<authorList>
<person name="Henriksen U."/>
<person name="Gether U."/>
<person name="Litman T."/>
</authorList>
<dbReference type="PubMed" id="15769853"/>
<dbReference type="DOI" id="10.1242/jcs.01729"/>
</citation>
<scope>MUTAGENESIS OF LYS-86</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>HOMODIMERIZATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="27841" last="27846">
<title>Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein.</title>
<authorList>
<person name="Wakabayashi K."/>
<person name="Nakagawa H."/>
<person name="Tamura A."/>
<person name="Koshiba S."/>
<person name="Hoshijima K."/>
<person name="Komada M."/>
<person name="Ishikawa T."/>
</authorList>
<dbReference type="PubMed" id="17686774"/>
<dbReference type="DOI" id="10.1074/jbc.c700133200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="3349" last="3356">
<title>The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells.</title>
<authorList>
<person name="Xie Y."/>
<person name="Xu K."/>
<person name="Linn D.E."/>
<person name="Yang X."/>
<person name="Guo Z."/>
<person name="Shimelis H."/>
<person name="Nakanishi T."/>
<person name="Ross D.D."/>
<person name="Chen H."/>
<person name="Fazli L."/>
<person name="Gleave M.E."/>
<person name="Qiu Y."/>
</authorList>
<dbReference type="PubMed" id="18056989"/>
<dbReference type="DOI" id="10.1074/jbc.m707773200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>PHOSPHORYLATION AT THR-362</scope>
<scope>MUTAGENESIS OF THR-362</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Lancet" volume="372" first="1953" last="1961">
<title>Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.</title>
<authorList>
<person name="Dehghan A."/>
<person name="Kottgen A."/>
<person name="Yang Q."/>
<person name="Hwang S.J."/>
<person name="Kao W.L."/>
<person name="Rivadeneira F."/>
<person name="Boerwinkle E."/>
<person name="Levy D."/>
<person name="Hofman A."/>
<person name="Astor B.C."/>
<person name="Benjamin E.J."/>
<person name="van Duijn C.M."/>
<person name="Witteman J.C."/>
<person name="Coresh J."/>
<person name="Fox C.S."/>
</authorList>
<dbReference type="PubMed" id="18834626"/>
<dbReference type="DOI" id="10.1016/s0140-6736(08)61343-4"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN UAQTL1 AND GOUT</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="10338" last="10342">
<title>Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.</title>
<authorList>
<person name="Woodward O.M."/>
<person name="Kottgen A."/>
<person name="Coresh J."/>
<person name="Boerwinkle E."/>
<person name="Guggino W.B."/>
<person name="Kottgen M."/>
</authorList>
<dbReference type="PubMed" id="19506252"/>
<dbReference type="DOI" id="10.1073/pnas.0901249106"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN UAQTL1</scope>
<scope>ASSOCIATION OF VARIANT LYS-141 WITH GOUT</scope>
<scope>CHARACTERIZATION OF VARIANT LYS-141</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Sci. Transl. Med." volume="1" first="5RA11" last="5RA11">
<title>Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.</title>
<authorList>
<person name="Matsuo H."/>
<person name="Takada T."/>
<person name="Ichida K."/>
<person name="Nakamura T."/>
<person name="Nakayama A."/>
<person name="Ikebuchi Y."/>
<person name="Ito K."/>
<person name="Kusanagi Y."/>
<person name="Chiba T."/>
<person name="Tadokoro S."/>
<person name="Takada Y."/>
<person name="Oikawa Y."/>
<person name="Inoue H."/>
<person name="Suzuki K."/>
<person name="Okada R."/>
<person name="Nishiyama J."/>
<person name="Domoto H."/>
<person name="Watanabe S."/>
<person name="Fujita M."/>
<person name="Morimoto Y."/>
<person name="Naito M."/>
<person name="Nishio K."/>
<person name="Hishida A."/>
<person name="Wakai K."/>
<person name="Asai Y."/>
<person name="Niwa K."/>
<person name="Kamakura K."/>
<person name="Nonoyama S."/>
<person name="Sakurai Y."/>
<person name="Hosoya T."/>
<person name="Kanai Y."/>
<person name="Suzuki H."/>
<person name="Hamajima N."/>
<person name="Shinomiya N."/>
</authorList>
<dbReference type="PubMed" id="20368174"/>
<dbReference type="DOI" id="10.1126/scitranslmed.3000237"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN UAQTL1</scope>
<scope>ASSOCIATION OF VARIANT LYS-141 WITH GOUT</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="10477" last="10486">
<title>Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.</title>
<authorList>
<person name="Takabe K."/>
<person name="Kim R.H."/>
<person name="Allegood J.C."/>
<person name="Mitra P."/>
<person name="Ramachandran S."/>
<person name="Nagahashi M."/>
<person name="Harikumar K.B."/>
<person name="Hait N.C."/>
<person name="Milstien S."/>
<person name="Spiegel S."/>
</authorList>
<dbReference type="PubMed" id="20110355"/>
<dbReference type="DOI" id="10.1074/jbc.m109.064162"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="16582" last="16587">
<title>Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.</title>
<authorList>
<person name="Brechbuhl H.M."/>
<person name="Gould N."/>
<person name="Kachadourian R."/>
<person name="Riekhof W.R."/>
<person name="Voelker D.R."/>
<person name="Day B.J."/>
</authorList>
<dbReference type="PubMed" id="20332504"/>
<dbReference type="DOI" id="10.1074/jbc.m109.090506"/>
</citation>
<scope>CAUTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="33123" last="33133">
<title>ABCG2 transports and transfers heme to albumin through its large extracellular loop.</title>
<authorList>
<person name="Desuzinges-Mandon E."/>
<person name="Arnaud O."/>
<person name="Martinez L."/>
<person name="Huche F."/>
<person name="Di Pietro A."/>
<person name="Falson P."/>
</authorList>
<dbReference type="PubMed" id="20705604"/>
<dbReference type="DOI" id="10.1074/jbc.m110.139170"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF HIS-583; CYS-603 AND TYR-605</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Nucleosides Nucleotides Nucleic Acids" volume="30" first="1091" last="1097">
<title>ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.</title>
<authorList>
<person name="Nakayama A."/>
<person name="Matsuo H."/>
<person name="Takada T."/>
<person name="Ichida K."/>
<person name="Nakamura T."/>
<person name="Ikebuchi Y."/>
<person name="Ito K."/>
<person name="Hosoya T."/>
<person name="Kanai Y."/>
<person name="Suzuki H."/>
<person name="Shinomiya N."/>
</authorList>
<dbReference type="PubMed" id="22132962"/>
<dbReference type="DOI" id="10.1080/15257770.2011.633953"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="131" last="132">
<title>ABCG2 null alleles define the Jr(a-) blood group phenotype.</title>
<authorList>
<person name="Zelinski T."/>
<person name="Coghlan G."/>
<person name="Liu X.Q."/>
<person name="Reid M.E."/>
</authorList>
<dbReference type="PubMed" id="22246507"/>
<dbReference type="DOI" id="10.1038/ng.1075"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN JR</scope>
<scope>VARIANT MET-12</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="174" last="177">
<title>Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior.</title>
<authorList>
<person name="Saison C."/>
<person name="Helias V."/>
<person name="Ballif B.A."/>
<person name="Peyrard T."/>
<person name="Puy H."/>
<person name="Miyazaki T."/>
<person name="Perrot S."/>
<person name="Vayssier-Taussat M."/>
<person name="Waldner M."/>
<person name="Le Pennec P.Y."/>
<person name="Cartron J.P."/>
<person name="Arnaud L."/>
</authorList>
<dbReference type="PubMed" id="22246505"/>
<dbReference type="DOI" id="10.1038/ng.1070"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN JR</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E50082" last="E50082">
<title>Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.</title>
<authorList>
<person name="Kobuchi H."/>
<person name="Moriya K."/>
<person name="Ogino T."/>
<person name="Fujita H."/>
<person name="Inoue K."/>
<person name="Shuin T."/>
<person name="Yasuda T."/>
<person name="Utsumi K."/>
<person name="Utsumi T."/>
</authorList>
<dbReference type="PubMed" id="23189181"/>
<dbReference type="DOI" id="10.1371/journal.pone.0050082"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="Front. Pharmacol." volume="4" first="138" last="138">
<title>ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.</title>
<authorList>
<person name="Gauthier C."/>
<person name="Ozvegy-Laczka C."/>
<person name="Szakacs G."/>
<person name="Sarkadi B."/>
<person name="Di Pietro A."/>
</authorList>
<dbReference type="PubMed" id="24312054"/>
<dbReference type="DOI" id="10.3389/fphar.2013.00138"/>
</citation>
<scope>CAUTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Placenta" volume="55" first="29" last="36">
<title>Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity.</title>
<authorList>
<person name="Szilagyi J.T."/>
<person name="Vetrano A.M."/>
<person name="Laskin J.D."/>
<person name="Aleksunes L.M."/>
</authorList>
<dbReference type="PubMed" id="28623970"/>
<dbReference type="DOI" id="10.1016/j.placenta.2017.04.006"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2019" name="Cell. Mol. Life Sci.">
<title>Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter.</title>
<authorList>
<person name="Zambo B."/>
<person name="Mozner O."/>
<person name="Bartos Z."/>
<person name="Toeroek G."/>
<person name="Varady G."/>
<person name="Telbisz A."/>
<person name="Homolya L."/>
<person name="Orban T.I."/>
<person name="Sarkadi B."/>
</authorList>
<dbReference type="PubMed" id="31254042"/>
<dbReference type="DOI" id="10.1007/s00018-019-03186-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT LYS-141; TRP-147; MET-153; LYS-360 DEL; CYS-373; MET-434 AND PRO-476</scope>
<scope>MUTAGENESIS OF MET-71; LYS-86 AND ARG-383</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2017" name="Nature" volume="546" first="504" last="509">
<title>Structure of the human multidrug transporter ABCG2.</title>
<authorList>
<person name="Taylor N.M.I."/>
<person name="Manolaridis I."/>
<person name="Jackson S.M."/>
<person name="Kowal J."/>
<person name="Stahlberg H."/>
<person name="Locher K.P."/>
</authorList>
<dbReference type="PubMed" id="28554189"/>
<dbReference type="DOI" id="10.1038/nature22345"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.78 ANGSTROMS) OF 2-655</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BOND</scope>
<scope>GLYCOSYLATION AT ASN-596</scope>
<scope>MUTAGENESIS OF GLU-211</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2018" name="Nat. Struct. Mol. Biol." volume="25" first="333" last="340">
<title>Structural basis of small-molecule inhibition of human multidrug transporter ABCG2.</title>
<authorList>
<person name="Jackson S.M."/>
<person name="Manolaridis I."/>
<person name="Kowal J."/>
<person name="Zechner M."/>
<person name="Taylor N.M.I."/>
<person name="Bause M."/>
<person name="Bauer S."/>
<person name="Bartholomaeus R."/>
<person name="Bernhardt G."/>
<person name="Koenig B."/>
<person name="Buschauer A."/>
<person name="Stahlberg H."/>
<person name="Altmann K.H."/>
<person name="Locher K.P."/>
</authorList>
<dbReference type="PubMed" id="29610494"/>
<dbReference type="DOI" id="10.1038/s41594-018-0049-1"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS) IN COMPLEX WITH INHIBITORS</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2018" name="Nature" volume="563" first="426" last="430">
<title>Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states.</title>
<authorList>
<person name="Manolaridis I."/>
<person name="Jackson S.M."/>
<person name="Taylor N.M.I."/>
<person name="Kowal J."/>
<person name="Stahlberg H."/>
<person name="Locher K.P."/>
</authorList>
<dbReference type="PubMed" id="30405239"/>
<dbReference type="DOI" id="10.1038/s41586-018-0680-3"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.09 ANGSTROMS) OF MUTANT GLN-211 IN COMPLEX WITH ATP</scope>
<scope>MUTAGENESIS OF GLU-211; THR-435; ASN-436; PHE-439; VAL-546; MET-549; LEU-554 AND LEU-555</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2002" name="J. Hum. Genet." volume="47" first="285" last="310">
<title>Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8.</title>
<authorList>
<person name="Iida A."/>
<person name="Saito S."/>
<person name="Sekine A."/>
<person name="Mishima C."/>
<person name="Kitamura Y."/>
<person name="Kondo K."/>
<person name="Harigae S."/>
<person name="Osawa S."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="12111378"/>
<dbReference type="DOI" id="10.1007/s100380200041"/>
</citation>
<scope>VARIANTS MET-12 AND LYS-141</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="Drug Metab. Pharmacokinet." volume="18" first="212" last="217">
<title>Eight novel single nucleotide polymorphisms in ABCG2/BCRP in Japanese cancer patients administered irinotacan.</title>
<authorList>
<person name="Itoda M."/>
<person name="Saito Y."/>
<person name="Shirao K."/>
<person name="Minami H."/>
<person name="Ohtsu A."/>
<person name="Yoshida T."/>
<person name="Saijo N."/>
<person name="Suzuki H."/>
<person name="Sugiyama Y."/>
<person name="Ozawa S."/>
<person name="Sawada J."/>
</authorList>
<dbReference type="PubMed" id="15618737"/>
<dbReference type="DOI" id="10.2133/dmpk.18.212"/>
</citation>
<scope>VARIANTS LEU-431 AND LEU-489</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2003" name="Pharmacogenetics" volume="13" first="19" last="28">
<title>Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.</title>
<authorList>
<person name="Zamber C.P."/>
<person name="Lamba J.K."/>
<person name="Yasuda K."/>
<person name="Farnum J."/>
<person name="Thummel K."/>
<person name="Schuetz J.D."/>
<person name="Schuetz E.G."/>
</authorList>
<dbReference type="PubMed" id="12544509"/>
<dbReference type="DOI" id="10.1097/00008571-200301000-00004"/>
</citation>
<scope>VARIANTS MET-12; LYS-141; LEU-206 AND TYR-590</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2005" name="Cancer Chemother. Pharmacol." volume="56" first="161" last="172">
<title>Single nucleotide polymorphisms modify the transporter activity of ABCG2.</title>
<authorList>
<person name="Morisaki K."/>
<person name="Robey R.W."/>
<person name="Oezvegy-Laczka C."/>
<person name="Honjo Y."/>
<person name="Polgar O."/>
<person name="Steadman K."/>
<person name="Sarkadi B."/>
<person name="Bates S.E."/>
</authorList>
<dbReference type="PubMed" id="15838659"/>
<dbReference type="DOI" id="10.1007/s00280-004-0931-x"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS MET-12; LYS-141 AND ASN-620</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="Drug Metab. Pharmacokinet." volume="21" first="109" last="121">
<title>Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population.</title>
<authorList>
<person name="Maekawa K."/>
<person name="Itoda M."/>
<person name="Sai K."/>
<person name="Saito Y."/>
<person name="Kaniwa N."/>
<person name="Shirao K."/>
<person name="Hamaguchi T."/>
<person name="Kunitoh H."/>
<person name="Yamamoto N."/>
<person name="Tamura T."/>
<person name="Minami H."/>
<person name="Kubota K."/>
<person name="Ohtsu A."/>
<person name="Yoshida T."/>
<person name="Saijo N."/>
<person name="Kamatani N."/>
<person name="Ozawa S."/>
<person name="Sawada J."/>
</authorList>
<dbReference type="PubMed" id="16702730"/>
<dbReference type="DOI" id="10.2133/dmpk.21.109"/>
</citation>
<scope>VARIANTS MET-12; LEU-13; LYS-141; GLN-160; ARG-354; LEU-431; ASN-441 AND LEU-489</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2019" name="Cells" volume="8">
<title>Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort.</title>
<authorList>
<person name="Toyoda Y."/>
<person name="Mancikova A."/>
<person name="Krylov V."/>
<person name="Morimoto K."/>
<person name="Pavelcova K."/>
<person name="Bohata J."/>
<person name="Pavelka K."/>
<person name="Pavlikova M."/>
<person name="Suzuki H."/>
<person name="Matsuo H."/>
<person name="Takada T."/>
<person name="Stiburkova B."/>
</authorList>
<dbReference type="PubMed" id="31003562"/>
<dbReference type="DOI" id="10.3390/cells8040363"/>
</citation>
<scope>VARIANTS TRP-147; MET-153; LYS-360 DEL; CYS-373; ALA-421; MET-434; PRO-476; ARG-572 AND ASN-620</scope>
<scope>CHARACTERIZATION OF VARIANTS LYS-141; TRP-147; MET-153; LYS-360 DEL; CYS-373; ALA-421; MET-434; PRO-476; ARG-572 AND ASN-620</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="7 10 12 14 15 19 25 27 28 30 31 32 35 37 39 40 41 49">Broad substrate specificity ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes a wide variety of physiological compounds, dietary toxins and xenobiotics from cells (PubMed:11306452, PubMed:12958161, PubMed:19506252, PubMed:20705604, PubMed:28554189, PubMed:30405239, PubMed:31003562). Involved in porphyrin homeostasis, mediating the export of protoporphyrin IX (PPIX) from both mitochondria to cytosol and cytosol to extracellular space, it also functions in the cellular export of heme (PubMed:20705604, PubMed:23189181). Also mediates the efflux of sphingosine-1-P from cells (PubMed:20110355). Acts as a urate exporter functioning in both renal and extrarenal urate excretion (PubMed:19506252, PubMed:20368174, PubMed:22132962, PubMed:31003562). In kidney, it also functions as a physiological exporter of the uremic toxin indoxyl sulfate (By similarity). Also involved in the excretion of steroids like estrone 3-sulfate/E1S, 3beta-sulfooxy-androst-5-en-17-one/DHEAS, and other sulfate conjugates (PubMed:12682043, PubMed:28554189, PubMed:30405239). Mediates the secretion of the riboflavin and biotin vitamins into milk (By similarity). Extrudes pheophorbide a, a phototoxic porphyrin catabolite of chlorophyll, reducing its bioavailability (By similarity). Plays an important role in the exclusion of xenobiotics from the brain (Probable). It confers to cells a resistance to multiple drugs and other xenobiotics including mitoxantrone, pheophorbide, camptothecin, methotrexate, azidothymidine, and the anthracyclines daunorubicin and doxorubicin, through the control of their efflux (PubMed:11306452, PubMed:12477054, PubMed:15670731, PubMed:18056989, PubMed:31254042). In placenta, it limits the penetration of drugs from the maternal plasma into the fetus (By similarity). May play a role in early stem cell self-renewal by blocking differentiation (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="10 12 15 41">
<text>ATP + H(2)O + xenobiotic(Side 1) = ADP + phosphate + xenobiotic(Side 2).</text>
<dbReference type="EC" id="7.6.2.2"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="27 30 32 40">
<text>urate(out) = urate(in)</text>
<dbReference type="Rhea" id="RHEA:60368"/>
<dbReference type="ChEBI" id="CHEBI:17775"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="32">
<dbReference type="Rhea" id="RHEA:60369"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>ATP + H2O + indoxyl sulfate(in) = ADP + H(+) + indoxyl sulfate(out) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61332"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:144643"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="7">
<dbReference type="Rhea" id="RHEA:61333"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="28">
<text>ATP + H2O + sphing-4-enine 1-phosphate(in) = ADP + H(+) + phosphate + sphing-4-enine 1-phosphate(out)</text>
<dbReference type="Rhea" id="RHEA:38951"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:60119"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="28">
<dbReference type="Rhea" id="RHEA:38952"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14 37 39">
<text>ATP + estrone 3-sulfate(in) + H2O = ADP + estrone 3-sulfate(out) + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61348"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:60050"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:61349"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>3beta-sulfooxy-androst-5-en-17-one(in) + ATP + H2O = 3beta-sulfooxy-androst-5-en-17-one(out) + ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61364"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:57905"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:61365"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>4-methylumbelliferone sulfate(in) + ATP + H2O = 4-methylumbelliferone sulfate(out) + ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61368"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:144581"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:61369"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl beta-D-glucuronate(in) + ATP + H2O = 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl beta-D-glucuronate(out) + ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61384"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:144584"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:61385"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>4-methylumbelliferone beta-D-glucuronate(in) + ATP + H2O = 4-methylumbelliferone beta-D-glucuronate(out) + ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61372"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:144582"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:61373"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate(in) + ATP + H2O = 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate(out) + ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61376"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:144583"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:61377"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>17beta-estradiol 17-O-(beta-D-glucuronate)(in) + ATP + H2O = 17beta-estradiol 17-O-(beta-D-glucuronate)(out) + ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:60128"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:82961"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:60129"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>ATP + H2O + methotrexate(in) = ADP + H(+) + methotrexate(out) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61356"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:50681"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="14">
<dbReference type="Rhea" id="RHEA:61357"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>ATP + H2O + riboflavin(in) = ADP + H(+) + phosphate + riboflavin(out)</text>
<dbReference type="Rhea" id="RHEA:61352"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:57986"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="7">
<dbReference type="Rhea" id="RHEA:61353"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="7">
<text>ATP + H2O + pheophorbide a(in) = ADP + H(+) + pheophorbide a(out) + phosphate</text>
<dbReference type="Rhea" id="RHEA:61360"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:58687"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="7">
<dbReference type="Rhea" id="RHEA:61361"/>
</physiologicalReaction>
</comment>
<comment type="activity regulation">
<text evidence="12">Specifically inhibited by the fungal toxin fumitremorgin C and Ko143.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="14">16.6 uM for estrone 3-sulfate</KM>
<KM evidence="14">1.23 mM for ATP</KM>
<KM evidence="14">12.9 uM for 4-methylumbelliferone sulfate</KM>
<KM evidence="14">26.9 uM for 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole sulfate</KM>
<KM evidence="32">8.24 mM for urate</KM>
<Vmax evidence="14">2.34 nmol/min/mg enzyme for estrone 3-sulfate transport</Vmax>
<Vmax evidence="32">6.96 nmol/min/mg enzyme for urate transport</Vmax>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="16 24 25 37">Homodimer; disulfide-linked (PubMed:15001581, PubMed:17686774, PubMed:18056989, PubMed:28554189). The minimal functional unit is a homodimer, but the major oligomeric form in plasma membrane is a homotetramer with possibility of higher order oligomerization up to homododecamers (PubMed:15001581).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1569435">
<id>Q9UNQ0</id>
</interactant>
<interactant intactId="EBI-1569435">
<id>Q9UNQ0</id>
<label>ABCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1569435">
<id>Q9UNQ0</id>
</interactant>
<interactant intactId="EBI-1018633">
<id>P11309-2</id>
<label>PIM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1569435">
<id>Q9UNQ0</id>
</interactant>
<interactant intactId="EBI-3390054">
<id>P0CG48</id>
<label>UBC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-20717342">
<id>Q9UNQ0-1</id>
</interactant>
<interactant intactId="EBI-20717342">
<id>Q9UNQ0-1</id>
<label>ABCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16 20 21 25 40 41">Cell membrane</location>
<topology evidence="8">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="27">Apical cell membrane</location>
<topology evidence="8">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Mitochondrion membrane</location>
<topology evidence="8">Multi-pass membrane protein</topology>
</subcellularLocation>
<text evidence="38">Enriched in membrane lipid rafts.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9UNQ0-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9UNQ0-2</id>
<name>2</name>
<sequence type="described" ref="VSP_014232 VSP_014233"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="15 42 43">Highly expressed in placenta (PubMed:9850061). Low expression in small intestine, liver and colon (PubMed:9861027). Expressed in brain (at protein level) (PubMed:12958161).</text>
</comment>
<comment type="domain">
<text evidence="31">The extracellular loop 3 (ECL3) is involved in binding porphyrins and transfer them to other carriers, probably albumin.</text>
</comment>
<comment type="PTM">
<text evidence="21 35">N-glycosylated (PubMed:15807535, PubMed:23189181). Glycosylation-deficient ABCG2 is normally expressed and functional.</text>
</comment>
<comment type="PTM">
<text evidence="25">Phosphorylated. Phosphorylation at Thr-362 by PIM1 is induced by drugs like mitoxantrone and is associated with cells increased drug resistance. It regulates the localization to the plasma membrane, the homooligomerization and therefore, the activity of the transporter.</text>
</comment>
<comment type="polymorphism">
<text evidence="33 34">Genetic variations in ABCG2 define the blood group Junior system (JR) [MIM:614490]. Individuals with Jr(a-) blood group lack the Jr(a) antigen on their red blood cells. These individuals may have anti-Jr(a) antibodies in their serum, which can cause transfusion reactions or hemolytic disease of the fetus or newborn. Although the clinical significance of the Jr(a-) blood group has been controversial, severe fatal hemolytic disease of the newborn has been reported. The Jr(a-) phenotype has a higher frequency in individuals of Asian descent, compared to those of European descent. The Jr(a-) phenotype is inherited as an autosomal recessive trait.</text>
</comment>
<comment type="polymorphism">
<text evidence="26 27 30">Genetic variations in ABCG2 influence the variance in serum uric acid concentrations and define the serum uric acid concentration quantitative trait locus 1 (UAQTL1) [MIM:138900]. Excess serum accumulation of uric acid can lead to the development of gout, a common disorder characterized by tissue deposition of monosodium urate crystals as a consequence of hyperuricemia (PubMed:18834626, PubMed:19506252, PubMed:20368174).</text>
</comment>
<comment type="similarity">
<text evidence="48">Belongs to the ABC transporter superfamily. ABCG family. Eye pigment precursor importer (TC 3.A.1.204) subfamily.</text>
</comment>
<comment type="caution">
<text evidence="29 36">Was originally proposed to function as a glutathione transporter (PubMed:20332504). However, some evidences suggest it is not the case (PubMed:24312054).</text>
</comment>
<comment type="sequence caution" evidence="48">
<conflict type="frameshift">
<sequence resource="EMBL" id="AF093771"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="48">
<conflict type="frameshift">
<sequence resource="EMBL" id="AF093772"/>
</conflict>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/abcg2/"/>
</comment>
<comment type="online information" name="ABCMdb">
<link uri="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=Q9UNQ0"/>
<text>Database for mutations in ABC proteins</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="https://web.expasy.org/spotlight/back_issues/222/"/>
<text>The unwalkable disease - Issue 222 of February 2020</text>
</comment>
<dbReference type="EC" id="7.6.2.2" evidence="10 41"/>
<dbReference type="EMBL" id="AF103796">
<property type="protein sequence ID" value="AAD09188.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF098951">
<property type="protein sequence ID" value="AAC97367.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB056867">
<property type="protein sequence ID" value="BAB39212.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB051855">
<property type="protein sequence ID" value="BAB46933.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY017168">
<property type="protein sequence ID" value="AAG52982.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY289766">
<property type="protein sequence ID" value="AAP44087.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY288307">
<property type="protein sequence ID" value="AAP31310.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF463519">
<property type="protein sequence ID" value="AAO14617.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY333755">
<property type="protein sequence ID" value="AAQ92941.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY333756">
<property type="protein sequence ID" value="AAQ92942.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK002040">
<property type="protein sequence ID" value="BAA92050.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290000">
<property type="protein sequence ID" value="BAF82689.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ996467">
<property type="protein sequence ID" value="ABI97388.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC084732">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC097484">
<property type="protein sequence ID" value="AAY40902.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021281">
<property type="protein sequence ID" value="AAH21281.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC092408">
<property type="protein sequence ID" value="AAH92408.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF093771">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF093772">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3628.1">
<molecule id="Q9UNQ0-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58910.1">
<molecule id="Q9UNQ0-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244315.1">
<molecule id="Q9UNQ0-2"/>
<property type="nucleotide sequence ID" value="NM_001257386.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004818.2">
<molecule id="Q9UNQ0-1"/>
<property type="nucleotide sequence ID" value="NM_004827.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005263412.1">
<molecule id="Q9UNQ0-1"/>
<property type="nucleotide sequence ID" value="XM_005263355.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011530722.1">
<molecule id="Q9UNQ0-1"/>
<property type="nucleotide sequence ID" value="XM_011532420.2"/>
</dbReference>
<dbReference type="PDB" id="5NJ3">
<property type="method" value="EM"/>
<property type="resolution" value="3.78"/>
<property type="chains" value="A/B=2-655"/>
</dbReference>
<dbReference type="PDB" id="5NJG">
<property type="method" value="EM"/>
<property type="resolution" value="3.78"/>
<property type="chains" value="A/B=2-655"/>
</dbReference>
<dbReference type="PDB" id="6ETI">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6FEQ">
<property type="method" value="EM"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6FFC">
<property type="method" value="EM"/>
<property type="resolution" value="3.56"/>
<property type="chains" value="A/B=2-655"/>
</dbReference>
<dbReference type="PDB" id="6HBU">
<property type="method" value="EM"/>
<property type="resolution" value="3.09"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6HCO">
<property type="method" value="EM"/>
<property type="resolution" value="3.58"/>
<property type="chains" value="A/B=2-655"/>
</dbReference>
<dbReference type="PDB" id="6HIJ">
<property type="method" value="EM"/>
<property type="resolution" value="3.56"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6HZM">
<property type="method" value="EM"/>
<property type="resolution" value="3.09"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6VXF">
<property type="method" value="EM"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6VXH">
<property type="method" value="EM"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6VXI">
<property type="method" value="EM"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDB" id="6VXJ">
<property type="method" value="EM"/>
<property type="resolution" value="4.10"/>
<property type="chains" value="A/B=1-655"/>
</dbReference>
<dbReference type="PDBsum" id="5NJ3"/>
<dbReference type="PDBsum" id="5NJG"/>
<dbReference type="PDBsum" id="6ETI"/>
<dbReference type="PDBsum" id="6FEQ"/>
<dbReference type="PDBsum" id="6FFC"/>
<dbReference type="PDBsum" id="6HBU"/>
<dbReference type="PDBsum" id="6HCO"/>
<dbReference type="PDBsum" id="6HIJ"/>
<dbReference type="PDBsum" id="6HZM"/>
<dbReference type="PDBsum" id="6VXF"/>
<dbReference type="PDBsum" id="6VXH"/>
<dbReference type="PDBsum" id="6VXI"/>
<dbReference type="PDBsum" id="6VXJ"/>
<dbReference type="SMR" id="Q9UNQ0"/>
<dbReference type="BioGRID" id="114821">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="DIP" id="DIP-29162N"/>
<dbReference type="IntAct" id="Q9UNQ0">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="MINT" id="Q9UNQ0"/>
<dbReference type="STRING" id="9606.ENSP00000237612"/>
<dbReference type="BindingDB" id="Q9UNQ0"/>
<dbReference type="ChEMBL" id="CHEMBL5393"/>
<dbReference type="DrugBank" id="DB12001">
<property type="generic name" value="Abemaciclib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08916">
<property type="generic name" value="Afatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11363">
<property type="generic name" value="Alectinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00437">
<property type="generic name" value="Allopurinol"/>
</dbReference>
<dbReference type="DrugBank" id="DB12015">
<property type="generic name" value="Alpelisib"/>
</dbReference>
<dbReference type="DrugBank" id="DB03496">
<property type="generic name" value="Alvocidib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11901">
<property type="generic name" value="Apalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB06605">
<property type="generic name" value="Apixaban"/>
</dbReference>
<dbReference type="DrugBank" id="DB15233">
<property type="generic name" value="Avapritinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11995">
<property type="generic name" value="Avatrombopag"/>
</dbReference>
<dbReference type="DrugBank" id="DB11817">
<property type="generic name" value="Baricitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00394">
<property type="generic name" value="Beclomethasone dipropionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB04851">
<property type="generic name" value="Biricodar"/>
</dbReference>
<dbReference type="DrugBank" id="DB12267">
<property type="generic name" value="Brigatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00921">
<property type="generic name" value="Buprenorphine"/>
</dbReference>
<dbReference type="DrugBank" id="DB06772">
<property type="generic name" value="Cabazitaxel"/>
</dbReference>
<dbReference type="DrugBank" id="DB00201">
<property type="generic name" value="Caffeine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04690">
<property type="generic name" value="Camptothecin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08907">
<property type="generic name" value="Canagliflozin"/>
</dbReference>
<dbReference type="DrugBank" id="DB09061">
<property type="generic name" value="Cannabidiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00958">
<property type="generic name" value="Carboplatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00482">
<property type="generic name" value="Celecoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00439">
<property type="generic name" value="Cerivastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04540">
<property type="generic name" value="Cholesterol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00515">
<property type="generic name" value="Cisplatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00242">
<property type="generic name" value="Cladribine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00631">
<property type="generic name" value="Clofarabine"/>
</dbReference>
<dbReference type="DrugBank" id="DB09065">
<property type="generic name" value="Cobicistat"/>
</dbReference>
<dbReference type="DrugBank" id="DB05239">
<property type="generic name" value="Cobimetinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00286">
<property type="generic name" value="Conjugated estrogens"/>
</dbReference>
<dbReference type="DrugBank" id="DB12483">
<property type="generic name" value="Copanlisib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00091">
<property type="generic name" value="Cyclosporine"/>
</dbReference>
<dbReference type="DrugBank" id="DB08912">
<property type="generic name" value="Dabrafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09102">
<property type="generic name" value="Daclatasvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB11963">
<property type="generic name" value="Dacomitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00970">
<property type="generic name" value="Dactinomycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB02115">
<property type="generic name" value="Daidzin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12941">
<property type="generic name" value="Darolutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09183">
<property type="generic name" value="Dasabuvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB01254">
<property type="generic name" value="Dasatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00694">
<property type="generic name" value="Daunorubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB11943">
<property type="generic name" value="Delafloxacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01234">
<property type="generic name" value="Dexamethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00255">
<property type="generic name" value="Diethylstilbestrol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01248">
<property type="generic name" value="Docetaxel"/>
</dbReference>
<dbReference type="DrugBank" id="DB08930">
<property type="generic name" value="Dolutegravir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00843">
<property type="generic name" value="Donepezil"/>
</dbReference>
<dbReference type="DrugBank" id="DB05928">
<property type="generic name" value="Dovitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00997">
<property type="generic name" value="Doxorubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00470">
<property type="generic name" value="Dronabinol"/>
</dbReference>
<dbReference type="DrugBank" id="DB11952">
<property type="generic name" value="Duvelisib"/>
</dbReference>
<dbReference type="DrugBank" id="DB04881">
<property type="generic name" value="Elacridar"/>
</dbReference>
<dbReference type="DrugBank" id="DB06210">
<property type="generic name" value="Eltrombopag"/>
</dbReference>
<dbReference type="DrugBank" id="DB13874">
<property type="generic name" value="Enasidenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00530">
<property type="generic name" value="Erlotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11827">
<property type="generic name" value="Ertugliflozin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00783">
<property type="generic name" value="Estradiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB13952">
<property type="generic name" value="Estradiol acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13953">
<property type="generic name" value="Estradiol benzoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13954">
<property type="generic name" value="Estradiol cypionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13955">
<property type="generic name" value="Estradiol dienanthate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13956">
<property type="generic name" value="Estradiol valerate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00655">
<property type="generic name" value="Estrone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00773">
<property type="generic name" value="Etoposide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00973">
<property type="generic name" value="Ezetimibe"/>
</dbReference>
<dbReference type="DrugBank" id="DB12500">
<property type="generic name" value="Fedratinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09279">
<property type="generic name" value="Fimasartan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00544">
<property type="generic name" value="Fluorouracil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00158">
<property type="generic name" value="Folic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB12010">
<property type="generic name" value="Fostamatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB02703">
<property type="generic name" value="Fusidic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00317">
<property type="generic name" value="Gefitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01645">
<property type="generic name" value="Genistein"/>
</dbReference>
<dbReference type="DrugBank" id="DB12141">
<property type="generic name" value="Gilteritinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11978">
<property type="generic name" value="Glasdegib"/>
</dbReference>
<dbReference type="DrugBank" id="DB13879">
<property type="generic name" value="Glecaprevir"/>
</dbReference>
<dbReference type="DrugBank" id="DB01016">
<property type="generic name" value="Glyburide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01094">
<property type="generic name" value="Hesperetin"/>
</dbReference>
<dbReference type="DrugBank" id="DB14538">
<property type="generic name" value="Hydrocortisone aceponate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14539">
<property type="generic name" value="Hydrocortisone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14540">
<property type="generic name" value="Hydrocortisone butyrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14541">
<property type="generic name" value="Hydrocortisone cypionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14542">
<property type="generic name" value="Hydrocortisone phosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14543">
<property type="generic name" value="Hydrocortisone probutate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14544">
<property type="generic name" value="Hydrocortisone valerate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09054">
<property type="generic name" value="Idelalisib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00762">
<property type="generic name" value="Irinotecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB11633">
<property type="generic name" value="Isavuconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB11757">
<property type="generic name" value="Istradefylline"/>
</dbReference>
<dbReference type="DrugBank" id="DB00602">
<property type="generic name" value="Ivermectin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00709">
<property type="generic name" value="Lamivudine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00448">
<property type="generic name" value="Lansoprazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB14723">
<property type="generic name" value="Larotrectinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11732">
<property type="generic name" value="Lasmiditan"/>
</dbReference>
<dbReference type="DrugBank" id="DB09027">
<property type="generic name" value="Ledipasvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB01097">
<property type="generic name" value="Leflunomide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09078">
<property type="generic name" value="Lenvatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB12070">
<property type="generic name" value="Letermovir"/>
</dbReference>
<dbReference type="DrugBank" id="DB13125">
<property type="generic name" value="Lusutrombopag"/>
</dbReference>
<dbReference type="DrugBank" id="DB14009">
<property type="generic name" value="Medical Cannabis"/>
</dbReference>
<dbReference type="DrugBank" id="DB00563">
<property type="generic name" value="Methotrexate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01204">
<property type="generic name" value="Mitoxantrone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00688">
<property type="generic name" value="Mycophenolate mofetil"/>
</dbReference>
<dbReference type="DrugBank" id="DB14011">
<property type="generic name" value="Nabiximols"/>
</dbReference>
<dbReference type="DrugBank" id="DB03467">
<property type="generic name" value="Naringenin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00220">
<property type="generic name" value="Nelfinavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB04868">
<property type="generic name" value="Nilotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09079">
<property type="generic name" value="Nintedanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00698">
<property type="generic name" value="Nitrofurantoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01051">
<property type="generic name" value="Novobiocin"/>
</dbReference>
<dbReference type="DrugBank" id="DB09074">
<property type="generic name" value="Olaparib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09296">
<property type="generic name" value="Ombitasvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00338">
<property type="generic name" value="Omeprazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB09330">
<property type="generic name" value="Osimertinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00526">
<property type="generic name" value="Oxaliplatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12612">
<property type="generic name" value="Ozanimod"/>
</dbReference>
<dbReference type="DrugBank" id="DB09073">
<property type="generic name" value="Palbociclib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00213">
<property type="generic name" value="Pantoprazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB09297">
<property type="generic name" value="Paritaprevir"/>
</dbReference>
<dbReference type="DrugBank" id="DB06589">
<property type="generic name" value="Pazopanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB13878">
<property type="generic name" value="Pibrentasvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB08860">
<property type="generic name" value="Pitavastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00175">
<property type="generic name" value="Pravastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00457">
<property type="generic name" value="Prazosin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00396">
<property type="generic name" value="Progesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04216">
<property type="generic name" value="Quercetin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01129">
<property type="generic name" value="Rabeprazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00481">
<property type="generic name" value="Raloxifene"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11855">
<property type="generic name" value="Revefenacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08864">
<property type="generic name" value="Rilpivirine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00740">
<property type="generic name" value="Riluzole"/>
</dbReference>
<dbReference type="DrugBank" id="DB12457">
<property type="generic name" value="Rimegepant"/>
</dbReference>
<dbReference type="DrugBank" id="DB08931">
<property type="generic name" value="Riociguat"/>
</dbReference>
<dbReference type="DrugBank" id="DB00503">
<property type="generic name" value="Ritonavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB06228">
<property type="generic name" value="Rivaroxaban"/>
</dbReference>
<dbReference type="DrugBank" id="DB09291">
<property type="generic name" value="Rolapitant"/>
</dbReference>
<dbReference type="DrugBank" id="DB01098">
<property type="generic name" value="Rosuvastatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12332">
<property type="generic name" value="Rucaparib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06654">
<property type="generic name" value="Safinamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01232">
<property type="generic name" value="Saquinavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB11689">
<property type="generic name" value="Selumetinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06290">
<property type="generic name" value="Simeprevir"/>
</dbReference>
<dbReference type="DrugBank" id="DB08934">
<property type="generic name" value="Sofosbuvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00795">
<property type="generic name" value="Sulfasalazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00669">
<property type="generic name" value="Sumatriptan"/>
</dbReference>
<dbReference type="DrugBank" id="DB01268">
<property type="generic name" value="Sunitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11644">
<property type="generic name" value="Tafamidis"/>
</dbReference>
<dbReference type="DrugBank" id="DB11760">
<property type="generic name" value="Talazoparib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00675">
<property type="generic name" value="Tamoxifen"/>
</dbReference>
<dbReference type="DrugBank" id="DB04348">
<property type="generic name" value="Taurocholic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB12887">
<property type="generic name" value="Tazemetostat"/>
</dbReference>
<dbReference type="DrugBank" id="DB01079">
<property type="generic name" value="Tegaserod"/>
</dbReference>
<dbReference type="DrugBank" id="DB00966">
<property type="generic name" value="Telmisartan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00444">
<property type="generic name" value="Teniposide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09299">
<property type="generic name" value="Tenofovir alafenamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB08880">
<property type="generic name" value="Teriflunomide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00624">
<property type="generic name" value="Testosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB13943">
<property type="generic name" value="Testosterone cypionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13944">
<property type="generic name" value="Testosterone enanthate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13946">
<property type="generic name" value="Testosterone undecanoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB11712">
<property type="generic name" value="Tezacaftor"/>
</dbReference>
<dbReference type="DrugBank" id="DB01685">
<property type="generic name" value="Topiroxostat"/>
</dbReference>
<dbReference type="DrugBank" id="DB01030">
<property type="generic name" value="Topotecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB14962">
<property type="generic name" value="Trastuzumab deruxtecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB11652">
<property type="generic name" value="Tucatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB15328">
<property type="generic name" value="Ubrogepant"/>
</dbReference>
<dbReference type="DrugBank" id="DB15091">
<property type="generic name" value="Upadacitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05294">
<property type="generic name" value="Vandetanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11613">
<property type="generic name" value="Velpatasvir"/>
</dbReference>
<dbReference type="DrugBank" id="DB08881">
<property type="generic name" value="Vemurafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11581">
<property type="generic name" value="Venetoclax"/>
</dbReference>
<dbReference type="DrugBank" id="DB00285">
<property type="generic name" value="Venlafaxine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00541">
<property type="generic name" value="Vincristine"/>
</dbReference>
<dbReference type="DrugBank" id="DB08828">
<property type="generic name" value="Vismodegib"/>
</dbReference>
<dbReference type="DrugBank" id="DB12026">
<property type="generic name" value="Voxilaprevir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00549">
<property type="generic name" value="Zafirlukast"/>
</dbReference>
<dbReference type="DrugBank" id="DB00495">
<property type="generic name" value="Zidovudine"/>
</dbReference>
<dbReference type="DrugCentral" id="Q9UNQ0"/>
<dbReference type="GuidetoPHARMACOLOGY" id="792"/>
<dbReference type="TCDB" id="3.A.1.204.2">
<property type="family name" value="the atp-binding cassette (abc) superfamily"/>
</dbReference>
<dbReference type="GlyGen" id="Q9UNQ0">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9UNQ0"/>
<dbReference type="PhosphoSitePlus" id="Q9UNQ0"/>
<dbReference type="BioMuta" id="ABCG2"/>
<dbReference type="DMDM" id="67462103"/>
<dbReference type="jPOST" id="Q9UNQ0"/>
<dbReference type="MassIVE" id="Q9UNQ0"/>
<dbReference type="PaxDb" id="Q9UNQ0"/>
<dbReference type="PeptideAtlas" id="Q9UNQ0"/>
<dbReference type="PRIDE" id="Q9UNQ0"/>
<dbReference type="ProteomicsDB" id="85323">
<molecule id="Q9UNQ0-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="85324">
<molecule id="Q9UNQ0-2"/>
</dbReference>
<dbReference type="ABCD" id="Q9UNQ0">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="14577">
<property type="antibodies" value="328 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="9429"/>
<dbReference type="Ensembl" id="ENST00000237612">
<molecule id="Q9UNQ0-1"/>
<property type="protein sequence ID" value="ENSP00000237612"/>
<property type="gene ID" value="ENSG00000118777"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000515655">
<molecule id="Q9UNQ0-2"/>
<property type="protein sequence ID" value="ENSP00000426917"/>
<property type="gene ID" value="ENSG00000118777"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000650821">
<molecule id="Q9UNQ0-1"/>
<property type="protein sequence ID" value="ENSP00000498246"/>
<property type="gene ID" value="ENSG00000118777"/>
</dbReference>
<dbReference type="GeneID" id="9429"/>
<dbReference type="KEGG" id="hsa:9429"/>
<dbReference type="UCSC" id="uc003hrg.4">
<molecule id="Q9UNQ0-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9429"/>
<dbReference type="DisGeNET" id="9429"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000118777.10"/>
<dbReference type="GeneCards" id="ABCG2"/>
<dbReference type="HGNC" id="HGNC:74">
<property type="gene designation" value="ABCG2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000118777">
<property type="expression patterns" value="Tissue enhanced (ductus deferens, intestine, seminal vesicle)"/>
</dbReference>
<dbReference type="MalaCards" id="ABCG2"/>
<dbReference type="MIM" id="138900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603756">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614490">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UNQ0"/>
<dbReference type="OpenTargets" id="ENSG00000118777"/>
<dbReference type="PharmGKB" id="PA390"/>
<dbReference type="eggNOG" id="KOG0061">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162658"/>
<dbReference type="HOGENOM" id="CLU_000604_57_8_1"/>
<dbReference type="InParanoid" id="Q9UNQ0"/>
<dbReference type="KO" id="K05681"/>
<dbReference type="OMA" id="GTQFTRG"/>
<dbReference type="OrthoDB" id="1022017at2759"/>
<dbReference type="PhylomeDB" id="Q9UNQ0"/>
<dbReference type="TreeFam" id="TF105211"/>
<dbReference type="PathwayCommons" id="Q9UNQ0"/>
<dbReference type="Reactome" id="R-HSA-189451">
<property type="pathway name" value="Heme biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-189483">
<property type="pathway name" value="Heme degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2161517">
<property type="pathway name" value="Abacavir transmembrane transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-917937">
<property type="pathway name" value="Iron uptake and transport"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9UNQ0"/>
<dbReference type="SIGNOR" id="Q9UNQ0"/>
<dbReference type="BioGRID-ORCS" id="9429">
<property type="hits" value="1 hit in 871 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ABCG2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="ABCG2"/>
<dbReference type="GenomeRNAi" id="9429"/>
<dbReference type="Pharos" id="Q9UNQ0">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9UNQ0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="Q9UNQ0">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000118777">
<property type="expression patterns" value="Expressed in jejunal mucosa and 205 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9UNQ0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UNQ0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031526">
<property type="term" value="C:brush border membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098591">
<property type="term" value="C:external side of apical plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031966">
<property type="term" value="C:mitochondrial membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016887">
<property type="term" value="F:ATPase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042626">
<property type="term" value="F:ATPase-coupled transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008559">
<property type="term" value="F:ATPase-coupled xenobiotic transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015225">
<property type="term" value="F:biotin transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015562">
<property type="term" value="F:efflux transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032217">
<property type="term" value="F:riboflavin transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015143">
<property type="term" value="F:urate transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042910">
<property type="term" value="F:xenobiotic transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015878">
<property type="term" value="P:biotin transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990748">
<property type="term" value="P:cellular detoxification"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006879">
<property type="term" value="P:cellular iron ion homeostasis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0140115">
<property type="term" value="P:export across plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032218">
<property type="term" value="P:riboflavin transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070633">
<property type="term" value="P:transepithelial transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055085">
<property type="term" value="P:transmembrane transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0150104">
<property type="term" value="P:transport across blood-brain barrier"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046415">
<property type="term" value="P:urate metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097744">
<property type="term" value="P:urate salt excretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990962">
<property type="term" value="P:xenobiotic transport across blood-brain barrier"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR003593">
<property type="entry name" value="AAA+_ATPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR013525">
<property type="entry name" value="ABC_2_trans"/>
</dbReference>
<dbReference type="InterPro" id="IPR003439">
<property type="entry name" value="ABC_transporter-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR030256">
<property type="entry name" value="ABCG2"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR19241:SF268">
<property type="entry name" value="PTHR19241:SF268"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01061">
<property type="entry name" value="ABC2_membrane"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00005">
<property type="entry name" value="ABC_tran"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00382">
<property type="entry name" value="AAA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50893">
<property type="entry name" value="ABC_TRANSPORTER_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-1278">Translocase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="chain" description="Broad substrate specificity ATP-binding cassette transporter ABCG2" id="PRO_0000093386">
<location>
<begin position="1"/>
<end position="655"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="8">
<location>
<begin position="1"/>
<end position="395"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="396"/>
<end position="416"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="8">
<location>
<begin position="417"/>
<end position="428"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="429"/>
<end position="449"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="8">
<location>
<begin position="450"/>
<end position="477"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="478"/>
<end position="498"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="8">
<location>
<begin position="499"/>
<end position="506"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="507"/>
<end position="527"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="8">
<location>
<begin position="528"/>
<end position="535"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="536"/>
<end position="556"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="8">
<location>
<begin position="557"/>
<end position="630"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="631"/>
<end position="651"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="8">
<location>
<begin position="652"/>
<end position="655"/>
</location>
</feature>
<feature type="domain" description="ABC transporter" evidence="9">
<location>
<begin position="37"/>
<end position="286"/>
</location>
</feature>
<feature type="domain" description="ABC transmembrane type-2">
<location>
<begin position="389"/>
<end position="651"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="4 5 9 39">
<location>
<begin position="80"/>
<end position="87"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="4 5 39">
<location>
<begin position="184"/>
<end position="190"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="4 5 39">
<location>
<position position="211"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="4 5 39">
<location>
<position position="243"/>
</location>
</feature>
<feature type="site" description="Not glycosylated" evidence="21">
<location>
<position position="418"/>
</location>
</feature>
<feature type="site" description="Not glycosylated" evidence="21">
<location>
<position position="557"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PIM1" evidence="25">
<location>
<position position="362"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 21 37">
<location>
<position position="596"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 24 37">
<location>
<begin position="592"/>
<end position="608"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="1 2 24 37">
<location>
<position position="603"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014232" evidence="47">
<original>IFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGE</original>
<variation>VCWSISQPLHLGCHGFSTSAFHDMDLRLCSIMNFWDKTSAQDSMQQETILVTMQHVLAKNIW</variation>
<location>
<begin position="550"/>
<end position="611"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014233" evidence="47">
<location>
<begin position="612"/>
<end position="655"/>
</location>
</feature>
<feature type="sequence variant" description="Found in Jr(a-) blood group phenotype; dbSNP:rs2231137." id="VAR_020779" evidence="11 13 22 23 34 44">
<original>V</original>
<variation>M</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1319203095." id="VAR_067363" evidence="23">
<original>S</original>
<variation>L</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism associated with high serum levels of uric acid and increased risk of gout; results in lower urate transport rates compared to wild-type; decreased protein abundance; dbSNP:rs2231142." id="VAR_020780" evidence="11 13 17 22 23 27 40 41 44 45">
<original>Q</original>
<variation>K</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of protein expression; loss of localization to the plasma membrane; dbSNP:rs372192400." id="VAR_082302" evidence="40 41">
<original>R</original>
<variation>W</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased protein abundance; no effect on localization to the plasma membrane; no effect on substrate transmembrane transport; decreased ATPase activity; no effect on ATPase-coupled transmembrane transporter activity; dbSNP:rs753759474." id="VAR_082303" evidence="40 41">
<original>T</original>
<variation>M</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs528655917." id="VAR_067364" evidence="23">
<original>R</original>
<variation>Q</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1061017." id="VAR_022704" evidence="15 42">
<original>Q</original>
<variation>E</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12721643." id="VAR_022705" evidence="13">
<original>I</original>
<variation>L</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1061018." id="VAR_022706" evidence="15 42">
<original>F</original>
<variation>S</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3116448." id="VAR_022707">
<original>S</original>
<variation>P</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41282401." id="VAR_030357" evidence="44">
<original>D</original>
<variation>H</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_022443" evidence="46">
<original>T</original>
<variation>P</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs138606116." id="VAR_067365" evidence="23">
<original>G</original>
<variation>R</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on protein abundance; no effect on localization to the plasma membrane; no effect on ATPase activity; no effect on substrate transmembrane transport." id="VAR_082304" evidence="40 41">
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased protein abundance; decreased localization to the plasma membrane; no effect on ATPase-coupled transmembrane transporter activity; dbSNP:rs752626614." id="VAR_082305" evidence="40 41">
<original>F</original>
<variation>C</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on protein abundance; no effect on substrate transmembrane transport; dbSNP:rs199854112." id="VAR_082306" evidence="40">
<original>T</original>
<variation>A</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_018349" evidence="18 23">
<original>F</original>
<variation>L</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on protein abundance; no effect on localization to the plasma membrane; increased ATPase activity; decreased ATPase-coupled transmembrane transporter activity; dbSNP:rs769734146." id="VAR_082307" evidence="40 41">
<original>T</original>
<variation>M</variation>
<location>
<position position="434"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1354553769." id="VAR_067366" evidence="23">
<original>S</original>
<variation>N</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on protein abundance; no effect on localization to the plasma membrane; no effect on ATPase activity; decreased ATPase-coupled transmembrane transporter activity; dbSNP:rs1274428653." id="VAR_082308" evidence="40 41">
<original>S</original>
<variation>P</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs192169063." id="VAR_018350" evidence="18 23">
<original>F</original>
<variation>L</variation>
<location>
<position position="489"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45605536." id="VAR_030358" evidence="44">
<original>A</original>
<variation>T</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9282571." id="VAR_022708">
<original>F</original>
<variation>I</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased protein abundance; loss of localization to the plasma membrane; dbSNP:rs200894058." id="VAR_082309" evidence="40">
<original>S</original>
<variation>R</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34264773." id="VAR_035355" evidence="13">
<original>N</original>
<variation>Y</variation>
<location>
<position position="590"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on protein abundance; no effect on substrate transmembrane transport; dbSNP:rs34783571." id="VAR_022709" evidence="22 40">
<original>D</original>
<variation>N</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased protein abundance. No effect on substrate transmembrane transport." evidence="41">
<original>M</original>
<variation>V</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased protein abundance. Decreased localization to the plasma membrane and retained intracellularly. Loss of ATPase-coupled transmembrane transporter activity." evidence="20 41">
<original>K</original>
<variation>M</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport." evidence="37 39">
<original>E</original>
<variation>Q</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by PIM1. Decreased localization to the plasma membrane. Decreased homooligomerization. Loss of function in resistance to drug treatment." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by PIM1. Constitutive drug resistance independent of PIM1." evidence="25">
<original>T</original>
<variation>D</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of protein expression." evidence="41">
<original>R</original>
<variation>C</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="21">
<original>N</original>
<variation>Q</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. Increased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased substrate-induced ATP hydrolysis. Increased substrate transport." evidence="39">
<original>T</original>
<variation>A</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport." evidence="39">
<original>T</original>
<variation>F</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport." evidence="39">
<original>N</original>
<variation>A</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport." evidence="39">
<original>F</original>
<variation>A</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases ATPase activity." evidence="19">
<original>R</original>
<variation>D</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases ATPase activity." evidence="19">
<original>R</original>
<variation>G</variation>
<variation>N</variation>
<variation>S</variation>
<variation>T</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in ATPase activity." evidence="19">
<original>R</original>
<variation>K</variation>
<variation>I</variation>
<variation>M</variation>
<variation>Y</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases transport activity." evidence="19">
<original>R</original>
<variation>T</variation>
<variation>Y</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. No effect on estrone-3 sulfate ATPase-coupled transmembrane transporter activity. No effect on substrate-induced ATP hydrolysis. No effect on substrate transport." evidence="39">
<original>V</original>
<variation>A</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased basal and substrate-induced ATP hydrolysis. Decreased substrate transport." evidence="39">
<original>V</original>
<variation>F</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. No effect on estrone-3 sulfate ATPase-coupled transmembrane transporter activity. No effect on substrate-induced ATP hydrolysis. No effect on substrate transport." evidence="39">
<original>M</original>
<variation>A</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on stability. Increased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased basal and substrate-induced ATP hydrolysis. Increased substrate transport." evidence="39">
<original>L</original>
<variation>A</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of protein expression." evidence="39">
<original>L</original>
<variation>A</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="21">
<original>N</original>
<variation>Q</variation>
<location>
<position position="557"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced binding to hemin but not to PPIX." evidence="31">
<original>H</original>
<variation>A</variation>
<location>
<position position="583"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation." evidence="21">
<original>N</original>
<variation>Q</variation>
<location>
<position position="596"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced binding to hemin but not to PPIX." evidence="31">
<original>C</original>
<variation>A</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on hemin binding." evidence="31">
<original>Y</original>
<variation>A</variation>
<location>
<position position="605"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD09188 and 7; AAP44087." ref="1 7" evidence="48">
<original>A</original>
<variation>V</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; BAA92050." ref="10" evidence="48">
<location>
<begin position="315"/>
<end position="316"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAH92408." ref="13" evidence="48">
<original>G</original>
<variation>V</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 14; AF093771/AF093772." ref="14" evidence="48">
<original>R</original>
<variation>G</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC97367." ref="2" evidence="48">
<original>R</original>
<variation>T</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 14; AF093772." ref="14" evidence="48">
<original>LP</original>
<variation>FT</variation>
<location>
<begin position="484"/>
<end position="485"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAG52982." ref="6" evidence="48">
<original>P</original>
<variation>A</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="37"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="66"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="73"/>
<end position="79"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="86"/>
<end position="93"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="99"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="104"/>
<end position="108"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="116"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="121"/>
<end position="124"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="136"/>
<end position="147"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="154"/>
<end position="168"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="172"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="188"/>
<end position="198"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="199"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="205"/>
<end position="211"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="218"/>
<end position="232"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="233"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="237"/>
<end position="241"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="247"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="254"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="263"/>
<end position="268"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="270"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="278"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="290"/>
<end position="297"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="298"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="303"/>
<end position="307"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="328"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="340"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="373"/>
<end position="390"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="393"/>
<end position="412"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="418"/>
<end position="421"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="423"/>
<end position="439"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="440"/>
<end position="447"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="448"/>
<end position="451"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="452"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="466"/>
<end position="478"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="479"/>
<end position="483"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="484"/>
<end position="492"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="493"/>
<end position="497"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="504"/>
<end position="528"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="535"/>
<end position="550"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="553"/>
<end position="556"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="558"/>
<end position="560"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="563"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="568"/>
<end position="570"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="573"/>
<end position="585"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="586"/>
<end position="588"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="597"/>
<end position="599"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="602"/>
<end position="605"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="610"/>
<end position="617"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="624"/>
<end position="649"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NJ3"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NJG"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6ETI"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6HBU"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6HZM"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6VXF"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q7TMS5"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00434"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11306452"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12111378"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12477054"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12544509"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12682043"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12958161"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15001581"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15618737"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15670731"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15769853"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15807535"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15838659"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16702730"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17686774"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056989"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18834626"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19506252"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20110355"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20332504"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20368174"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20705604"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22132962"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22246505"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22246507"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23189181"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24312054"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28554189"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28623970"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30405239"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31003562"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31254042"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9850061"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9861027"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source ref="11"/>
</evidence>
<evidence key="45" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="46" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000305"/>
<evidence key="49" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12958161"/>
</source>
</evidence>
<sequence length="655" mass="72314" checksum="A8AF66B96034C5A8" modified="2005-05-10" version="3">MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

